Topline data from Hengrui’s Phase II trial for its GLP-1/GIP product demonstrated a statistically significant mean weight loss of 22.8%.

The glucagon-like peptide-1 receptor (GLP-1R) market experienced significant growth in 2023, generating $37.2 billion in ...

The market outlook for these products is equally promising ... These estimations further highlight the lucrative potential offered by GLP-1Rs for both industry giants and innovative smaller players ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...

As product reviewers, we spend the entirety of the year testing and writing about products — ones that add joy and value, make life easier, and help you live better — and we love getting the ...

One thing remained consistent: our readers love shopping for products on Amazon, and specifically look forward to the retailer’s deals throughout the year. They took advantage of some of the ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that the U.S. Food and Drug Administration (FDA) has ...

However, analysts expect the picture is set to shift over the next decade, pointing to the 323 active GLP-1Rs currently in the pipeline.

If you click on links we provide, we may receive compensation. It’s the little things that make life better Caraway; Kizik; Nordstrom; Amazon Out with the old and in with the new! If you haven ...

Our guide to upcoming products provides an overview of all of the new devices that we're expecting to see in 2025, based on the most current rumors. The dates listed here are not always concrete ...